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INTRODUCTION: Vitamin D deficiency is linked to poor treatment response in patients with Multiple S clerosis. The
aim of this study is to define the frequency of Vitamin D deficiency for early detection and timely intervention leading
to improved morbidity rates.
OBJECTIVE: To determine the frequency of vitamin D deficiency in Multiple sclerosis patients present at neurology
ward of a tertiary care hospital in Larkana
DURATION OF STUDY: March 2016 to August 2016
STUDY DESIGN: Cross-sectional study
Setting: Neurology Ward Chandka Medical College Hospital, Larkana
SUBJECTS: Ages of 18 and 60 years, either gender, diagnosis of MS for more than 3 months, sun exposure for at least
30 minutes thrice per week for and give written informed consent were included in this study.
METHODS: This study was approved by an ethical review committee of the institute. Patients fulfilling inclusion criteria
were enrolled in this study after taking written informed consent. The demographic variables like name, age, gender,
duration of sun exposure & duration of disease were collected by the researcher. Blood Sample for a vitamin D level
blood sample of these patients was drawn on the same day and sent to a laboratory for vitamin D level in the
pathological lab of CMCH. Blood Vitamin D levels in this study were measured by radioimmunoassay. The data was
analyzed using SPSS version 19.
RESULTS: Mean age of enrolled participants was 43.6±11 years. Of 85 enrolled participants, 36 (42.4%) were male
and 49 (57.6%) were female, the mean duration of disease was 6.2±1.4 months, 70 (82.4%) participants were
married and 15 (17.6%) were unmarried, 49 (57.6%) were employed, 43 (50.6%) were exposed to the sun for < 40
minutes a day. The frequency of vitamin D deficiency among patients with multiple sclerosis was 17 (20%) cases.
CONCLUSIONS: It is concluded from this study that the frequency of vitamin D deficiency among patients with multiple
sclerosis was 20%.
KEYWORDS: Multiple sclerosis, vitamin D deficiency, sun exposure
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INTRODUCTION:

vitamin D for 28 weeks showed a decline in the number
of gadolinium-enhancing lesions on magnetic
resonance imaging per patient; this led to a 25(OH)D
serum concentration of 386 nmol/L (158 ng/mL)
without causing hypercalcemia, hypercalciuria, or other
complication.13
Ongoing, Randomized control trials are assessing
vitamin D supplementation for the treatment and
prevention of MS.14

Multiple sclerosis (MS) is an autoimmune,
inflammatory,
neurodegenerative,
T-lymphocyte-mediated disease of uncertain etiology.
Mostly it is because of genetic susceptibility;
epidemiologic studies suggest environmental influence
because the development of MS correlates most
strongly with rising latitude in both the northern and
southern hemispheres1.

RATIONALE:

The diagnosis relies on recognition of the clinical
patterns of the disease. Relapsing and remitting
neurologic deficits is the hallmark of the disease in
most patients. The pathologic hallmark of MS is focal
demyelination within the brain and spinal cord.
Although the lesions can occur at any site within the
central nervous system, they have a predilection for
involvement of the periventricular white matter, the
corpus callosum, optic nerves, and the dorsal spinal
cord. MS affects females two to three times more than
male, risk increases from adolescence up to the age of
35 and then gradually declines and is rare after the age
of 65. MS is rare in equatorial climates, and its
prevalence increases with distance from the equator.
Higher latitudes result in lower ultraviolet radiation
exposure and lower vitamin D levels2, from the relation
with latitude; it appears that low solar UltraVoilet B
(UVB) doses during winter are an important risk
factor3.However, low UVB exposure in summer also
plays a role. This is an observation that MS patients
consistently have lower levels of vitamin D. one recent
study has shown prevalence of vitamin D as 17% in
patients with MS.4It is suggested that vitamin D may
help to decrease the risk of MS and those patients with
higher vitamin D levels are less likely to develop MS.5
It is observed that higher vitamin D levels may help to
reduce MS activity and a slower the rate of progression
of MS.6 Higher vitamin D levels also helps to prevent
disability in MS patients.7A case-control study
compared the serum vitamin D levels of 103 MS
patients with 110 controls and found that for every
10-nmol/L increase in serum 25(OH)D level the odds of
MS was reduced by 19% in women, suggesting a
“protective” effect of higher vitamin D levels.8 In
addition, a negative correlation was found between
Expanded Disability Status Scale scores among female
MS patients and 25(OH)D levels. There are several
other studies have supported the finding that lower
levels of vitamin D in MS patients are associated with
more severe disability.9 Lower levels during relapses
have also been reported in patients with
relapse-remitting MS.10-12One small safety study of
12 patients taking 1000 µg per day (40,000 IU) of
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The rationale of study is that the studies on the subject
under consideration are scarce in Pakistan and
secondly most of the studies done on retrospective
data. Since VIT D deficiency is related to poor
treatment results in patients with MS, this study by
determining the frequency was lead to realization for
early detection and timely intervention ultimately
leading to improved morbidity rates.
OBJECTIVE
To determine the frequency of vitamin D deficiency in
Multiple sclerosis patients present at neurology ward of
a tertiary care hospital in Larkana.
OPERATIONAL DEFINITION
MULTIPLE SCLEROSIS:
Was defined as isolated limb weakness of power<2/5
on MRC score with the increased tone of > 2 scores
determined by Modified Ashworth Scale on clinical
examination > 3 months (Appendix I and II respectively
) and according to the 2010 McDonald diagnostic
criteria of MS (Appendix ΙΙΙ)
VITAMIN D DEFICIENCY:
Patients were labeled Vitamin D deficient if less than
25 nmol/l at the time of presentation.
MATERIAL AND METHOD
Study Design: Cross-sectional study
Setting: This study was conducted at the Neurology
Ward Chandka Medical College Hospital, Larkana.
Duration of Study: Six months March 2016 to August
2016
Sample Size: Taking the prevalence of VIT D
deficiency as 17%4, confidence interval at 95% and
margin of error at 8% and putting this information in Epi
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Info 7, the sample size calculated is 85.

Data was analyzed on a computer using SPSS software
version 21. Mean and SD was calculated for age,
duration of disease, duration of sun exposure and
Vitamin D levels. Frequency and percentages were
calculated for gender, age group, marital status, and
employment status and outcome variable i-e vitamin D
deficiency. Effect variable like age, gender, marital
status, and employment status, duration of sun
exposure and duration of disease were stratified to see
the effects of these on the outcome variable. Applying
chi-square test with p value <0.05 taken as significant.

Sampling Technique: Non - Probability consecutive
sampling
Inclusion Criteria:
1. Between the ages of 18 and 60 years,
2. Both genders
3. Diagnosis of MS as per operational definition for
> 3 months
4. Give written informed consent prior to any
testing under this protocol, including screening
tests and evaluations that are not considered part
of the subject's routine care.
5. Sun exposure for at least 30minutes thrice per
week

Ethical consideration:
Permission for data collection was taken from the head
of the department of the ward. Written informed
consent was obtained from patients while ensuring that
the data was kept confidential. Patients were
thoroughly informed about the objectives and methods
of the study.

Exclusion Criteria:
1. Patients that have other co-morbidities like
heart failure determined by echo as EF>25
renal disease determined by serum Cr > 3mg/dl)
2. Endocrine disorders like
hyperparathyroidism
determined by blood PTH levels > 10 ng/dl
3. Any patient on long-term steroid treatment for
less than 3 months. determined by
physician prescription slip
4. Patients already on vitamin D therapy for more
than 3 months. Doctor’s prescription as evidence.

RESULTS
A total of 85 patients were enrolled in this study during
study period. The mean age of enrolled participants
was 43.6±11 years. Majority of patients were less
than 45 years accounting for 43 (50.6%) cases. Of 85
enrolled participants, 36 (42.4%) were male and 49
(57.6%) were female, the mean duration of disease
was 6.2±1.4 months, 70 (82.4%) participants were
married and 15 (17.6%) were unmarried , 49 (57.6%)
were employed, 43 (50.6%) were exposed to the sun
for < 40 minutes a day (Graph 1).

Data collection procedure:
The permission for the data collection was sought from
the Ethical review committee of the hospital, the study
was conducted in the department of Neurology,
department, Chandka Medical College, Larkana. After
taking the informed written consent from the patients.
Diagnosed cases of Multiple sclerosis was enrolled in
the study after fulfilling inclusion/exclusion criteria. The
researcher was collect data on a prescribed
questionnaire regarding demographic variables like
name, age, gender, duration of sun exposure &
duration of disease. Blood Sample for a vitamin D level
blood sample of these patients was drawn on the same
day and sent to a laboratory for vitamin D level in the
pathological lab of CMCH. Blood Vitamin D levels in this
study was measured by radioimmunoassay. The test
was done free of cost at CMCH, Larkana lab and the
results of these tests were collected on reporting date
and was entered on the Performa by researcher herself.

Outcome of study
The frequency of vitamin D deficiency among patients
with multiple sclerosis was 17 (20%) cases (Graph 2)
Stratified analysis:
Stratified analysis of frequency of vitamin D deficiency
among patients with multiple sclerosis by age, gender,
duration of disease, duration of sun exposure, marital
status and employment status is summarized in tables
1-6.
Stratified analysis by age:
Of patients <45 years of age, 9 (20.9%) had vitamin D
deficiency compared to 8 (19%) cases among patients
of age >= 45 years (p-0.522).

Data analysis procedure:
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Stratified analysis by gender:

Graph 2:
FREQUENCY OF VITAMIN D DEFICIENCY
PATIENTS WITH MULTIPLE SCLEROSIS
(n=143)

Of male patients, 3 (8.3%) had vitamin D deficiency
compared to 14 (28.6%) cases among female patients
(p-0.019).
Stratified analysis by duration of disease: Of
patients with duration of disease of <6 months of age,
8 (14.8%) had vitamin D deficiency compared to 9
(29%) cases among patients of with duration of
disease >= 6 months (p-0.099).

IN

Stratified analysis by duration of exposure to the
sun: Of patients with duration of sun exposure <40
minutes, 11 (25.6%) had vitamin D deficiency
compared to 6 (14.3%) cases among patients of with
duration exposure to the sun >= 40 minutes
(p-0.151).
Stratified analysis by marital status:
Of married patients, 15 (21.4%) had vitamin D
deficiency compared to 2 (13.3%) cases among
unmarried patients (p-0.378).

Table 1: STRATIFIED ANALYSIS OF FREQUENCY OF
VITAMIN D DEFICIENCY IN PATIENTS WITH
MULTIPLE SCLEROSIS BY AGE

Stratified analysis by employment status:
Of employed patients, 14 (28.6%) had vitamin D
deficiency compared to 3 (8.3%) cases among
unemployed patients (p-0.019).
Graph 1:
DISTRIBUTION OF EXPOSURE TO SUN AMONG
ENROLLED PARTICIPANTS
(n=85)

Table 2:
STRATIFIED ANALYSIS OF FREQUENCY OF VITAMIN
D DEFICIENCY IN PATIENTS WITH MULTIPLE
SCLEROSIS BY SEX
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Table 3:
STRATIFIED ANALYSIS OF FREQUENCY OF VITAMIN
D DEFICIENCY IN PATIENTS WITH MULTIPLE
SCLEROSIS BY DURATION OF
DISEASE

Table 6:
STRATIFIED ANALYSIS OF FREQUENCY OF VITAMIN
D DEFICIENCY IN PATIENTS WITH MULTIPLE
SCLEROSIS BY EMPLOYMENT STATUS

Table 4:
STRATIFIED ANALYSIS OF FREQUENCY OF VITAMIN
D DEFICIENCY IN PATIENTS WITH MULTIPLE
SCLEROSIS BY DURATION OF SUN EXPOSURE as

DISCUSSION
Hypovitaminosis D is currently one of the most studied
environmental risk factors for multiple sclerosis (MS)
and is potentially the most promising in terms of new
clinical implications. The putative protective role of
vitamin D in MS is based on a wide-ranging series of
arguments. The first group of arguments exists outside
of, or indeed before, the disease, including
physiological,
metabolic,
experimental
and
immunological factors, in addition to which there are
epidemiological data on the effects of latitude, past
exposure to sunlight and serum vitamin D levels on the
risk of MS in the general population. The second group
of arguments stems from data on MS patients derived
from biological and therapeutic studies.
Diseases that affect central nervous system myelin can
be categorized as demyelinating (acquired, usually
inflammatory) and dysmyelinating (abnormal formation
of myelin, usually due to a genetic disease). The most
common autoimmune inflammatory demyelinating
disease of the central nervous system is multiple
sclerosis (MS).
Several studies have shown that vitamin D levels are
lower in MS patients than in controls.15-20 In this
study, the frequency of vitamin D deficiency among
patients with multiple sclerosis was 17 (20%). A recent
study24 showed that in clinically isolated syndrome
patients (namely, those suffering a single demyelinating
attack that is compatible with MS), vitamin D deficiency
was a predictor of developing clinically definite MS. The
association of disease activity with vitamin D levels in
MS patients has been evaluated in multiple studies
that demonstrated a lower MS relapse rate in patients
with higher levels of vitamin D. Additionally, low levels of

Table 5:
STRATIFIED ANALYSIS OF FREQUENCY OF VITAMIN
D DEFICIENCY IN PATIENTS WITH MULTIPLE
SCLEROSIS BY MARITAL STATUS
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